Literature DB >> 17324606

Cytokines and chronic liver disease.

Leonardo Fainboim1, Alejandra Cherñavsky, Natalia Paladino, Ana C Flores, Lourdes Arruvito.   

Abstract

From an immunological point of view, the healthy liver has been usually associated with the phenomenon of tolerance. A microenvironment of regulatory cytokines produced by liver Kuppfer cells and liver sinusoidal endothelial cells has contributed, together with resident dendritic cells, to generate a tolerogenic environment in this tissue. In this review we discussed the intrahepatic responses to different sorts of liver injury, such as hepatotrophic viruses, alcohol or putative self-antigens. In each case we analyzed the impact of different cytokines in the clinical outcome of the different pathological situations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17324606     DOI: 10.1016/j.cytogfr.2007.01.017

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  11 in total

1.  The human fetal immune response to hepatitis C virus exposure in utero.

Authors:  Jennifer M Babik; Deborah Cohan; Alexander Monto; Dennis J Hartigan-O'Connor; Joseph M McCune
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

Review 2.  Toxicological effect of engineered nanomaterials on the liver.

Authors:  A Kermanizadeh; B K Gaiser; H Johnston; D M Brown; V Stone
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

3.  Regulation of immune response and inflammatory reactions against viral infection by VCAM-1.

Authors:  Rong Ou; Menghua Zhang; Lei Huang; Richard A Flavell; Pandelakis A Koni; Demetrius Moskophidis
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

4.  Inhibition of neddylation represses lipopolysaccharide-induced proinflammatory cytokine production in macrophage cells.

Authors:  Fang-Mei Chang; Sara M Reyna; Jose C Granados; Sung-Jen Wei; Wendy Innis-Whitehouse; Shivani K Maffi; Edward Rodriguez; Thomas J Slaga; John D Short
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

Review 5.  Arsenic and cardiovascular disease.

Authors:  J Christopher States; Sanjay Srivastava; Yu Chen; Aaron Barchowsky
Journal:  Toxicol Sci       Date:  2008-11-17       Impact factor: 4.849

6.  Apelin serum level in Egyptian patients with chronic hepatitis C.

Authors:  Hala O El-Mesallamy; Nadia M Hamdy; Hanan H Rizk; Abdel-Rahman El-Zayadi
Journal:  Mediators Inflamm       Date:  2011-10-04       Impact factor: 4.711

7.  Analytical assessment of interleukin - 23 and -27 cytokines in healthy people and patients with hepatitis C virus infection (genotypes 1 and 3a).

Authors:  Asghar Ashrafi Hafez; Abbas Ahmadi Vasmehjani; Rasoul Baharlou; Seyed Dawood Mousavi Nasab; Mohammad Hasan Davami; Ahmad Najafi; Negar Joharinia; Hasan Rezanezhad; Nayeb Ali Ahmadi; Masoumeh Imanzad
Journal:  Hepat Mon       Date:  2014-09-27       Impact factor: 0.660

8.  Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model.

Authors:  Ali Kermanizadeh; Mille Løhr; Martin Roursgaard; Simon Messner; Patrina Gunness; Jens M Kelm; Peter Møller; Vicki Stone; Steffen Loft
Journal:  Part Fibre Toxicol       Date:  2014-10-20       Impact factor: 9.400

9.  Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India.

Authors:  Nandana Das; Somnath Paul; Debmita Chatterjee; Nilanjana Banerjee; Niladri S Majumder; Nilendu Sarma; Tanmoy J Sau; Santanu Basu; Saptarshi Banerjee; Papiya Majumder; Apurba K Bandyopadhyay; J Christopher States; Ashok K Giri
Journal:  BMC Public Health       Date:  2012-08-10       Impact factor: 3.295

10.  HIV-1 coinfection profoundly alters intrahepatic chemokine but not inflammatory cytokine profiles in HCV-infected subjects.

Authors:  Sishun Hu; Marwan Ghabril; Tohti Amet; Ningjie Hu; Daniel Byrd; Kai Yang; Raj Vuppalanchi; Romil Saxena; Mona Desai; Jie Lan; Raymond Johnson; Samir Gupta; Naga Chalasani; Qigui Yu
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.